mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.3 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.3 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.3 |